Model
Edge
Seres Therapeutics
0001767321
Filing Type
4
Filing Date
10/28/2024
Updated
10/29/24, 4:27 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership